|
|
|
|
| |
TAKE THIS POLL |
|
|
- In Patients With Metastatic Prostate Cancer Therapeutic Vaccine Prolongs Survival And Improves Quality Of Life 17 May 2008 07:38 GMT
... of the American Urological Association in Orlando. In recent years, the concept of vaccine immunotherapy for advanced prostate cancer has become increasingly high profile as research has expanded. Major advances ...
- Life-saving canine 17 May 2008 05:46 GMT
... various forms of cancer. Treatments - including surgery, radiation therapy, chemotherapy, hormone therapy and immunotherapy - help rid the body of cancer or force it into remission. Detecting cancer early, before ...
- Omrix Biopharmaceuticals 17 May 2008 04:38 GMT
... Biopharmaceuticals (Nasdaq: ), a small-cap firm that operates in the biosurgical products and passive immunotherapy markets. The stock has a market capitalization of $261 million. The company's biosurgical products are ...
- AVANT Announces Temporary Postponement of Conference Call 16 May 2008 23:19 GMT
... will finalize its filings and reschedule the call as soon as is practicable. AVANT Immunotherapeutics, Inc. is a NASDAQ-listed company discovering and developing innovative vaccines and targeted immunotherapeutics for ...
- CEL-SCI Corporation Reports Second Quarter 2008 Financial Results 16 May 2008 19:49 GMT
... cancer drug. Multikine, a patented defined mixture of naturally derived cytokines, is the first immunotherapeutic agent in a new class of drugs called "Immune SIMULATORS". Immune SIMULATORS simulate the ...
- Medarex Announces June 2nd Webcast Review and Discussion of Ipilimumab Data Presented at ASCO 16 May 2008 12:42 GMT
... and new lesions in advanced melanoma patients on ipilimumab treatment" (Abstract #3020, Developmental Therapeutics: Immunotherapy Session) - Poster presentation and discussion from 2:00 p.m. to 6:00 p.m. local time on ...
- The ASCO Cancer Foundation Awards $7.6 Million to Further Progress Against Cancer 16 May 2008 12:36 GMT
... year's recipients include patient use of complementary and alternative medicine, the investigation of new immunotherapy treatments, and the incorporation of personalized medicine and gene therapy strategies for the treatment of ...
- Newsletter Watch: Omrix Biopharmaceuticals 16 May 2008 12:31 GMT
... Biopharmaceuticals (Nasdaq: ), a small-cap firm that operates in the biosurgical products and passive immunotherapy markets. The stock has a market capitalization of $261 million. The company's biosurgical products are ...
- New Hope For UK Follicular Lymphoma Patients As Zevalin(R), [90Y]-ibritumomab Tiuxetan, Licenced For First Line Consolidation Therapy 16 May 2008 11:32 GMT
... Amsterdam, the Netherlands, lead investigator of the FIT trial. "The results also show that radioimmunotherapy is a very effective single agent in the treatment of follicular lymphoma." Zevalin was originally ...
- First Conclusive Evidence Of Alzheimer's-Like Brain Tangles In Nonhuman Primates, Findings Could Pave Way For New Human Treatments 16 May 2008 08:17 GMT
... primate species with the hope of identifying the correct target for new drugs and immunotherapy. Rosen noted Yerkes has provided her with unparalleled access to resources for graduate-level research and ...
- Rodman & Renshaw Global Healthcare Conference 2008 Presenter Profiles 16 May 2008 08:15 GMT
... is focused on developing multiple DNA- based immunotherapies and DNA vaccines. Inovio is a leader in developing human applications of electroporation, using brief, ...
- Cancer Research Group Releases Data 16 May 2008 05:54 GMT
... all be closely watched at the meeting. On the experimental side, data on Avant Immunotherapeutics' ( ) vaccine for brain tumors interests investors, as does a melanoma drug developed ...
- Comprehensive Approach to the Biology of Extracellular Molecular Chaperones 16 May 2008 05:45 GMT
... HSP60 speaks to the immune system in many voices - Cell stress proteins: novel immunotherapeutics - Cell stress proteins as modulators of bacteria-host interactions 141 Chaperonin 60 and macrophage ...
- Omrix Biopharmaceuticals Announces Larry Ellberger's Appointment as Chairman of the Board and the Election of Pamela McNamara as a New Director 15 May 2008 23:28 GMT
... and Nominating Committee. Mr. Ellberger is also a member of the Board of AVANT Immunotherapeutics, Inc. and TransPharma Medical(TM) Ltd., and is a Founding Partner of consulting firm HVA, ...
- Vaccine Provides Help For Prostate Cancer Patients 15 May 2008 15:59 GMT
... of the American Urological Association in Orlando. In recent years, the concept of vaccine immunotherapy for advanced prostate cancer has become increasingly high profile as research has expanded. Major advances ...
- First Conclusive Evidence Of Alzheimer's-like Brain Tangles In Nonhuman Primates Found 15 May 2008 15:58 GMT
... primate species with the hope of identifying the correct target for new drugs and immunotherapy. Rosen noted Yerkes has provided her with unparalleled access to resources for graduate-level research and ...
- New Data on Bristol-Myers Squibb Oncology Compounds to Be Featured in More Than 100 Abstracts at ASCO 2008 15 May 2008 15:52 GMT
... tumor types. Bristol-Myers Squibb and its partner Medarex will present data on the investigational immunotherapy ipilimumab. New Phase 2 ipilimumab data will evaluate the medicine's potential in patients with metastatic ...
- The 10th Annual C21 BioVentures Presenter Profiles 15 May 2008 14:52 GMT
... Pharmaceuticals, Inc Phone: 858-731-8520 E-mail: xfrapaise@aspheliapharma.com Web: San Diego-based Asphelia Pharmaceuticals is a fast-growing immunotherapeutic company focused on the development of therapies for Inflammatory Bowel Disease (Crohn's Disease and ...
- Novel Microparticle Offers Immunological Breakthrough Against a Range of Infectious Diseases and Potentially Some Cancers 15 May 2008 14:50 GMT
... range of indications. 2) Leveraging New Zealand's unique livestock disease-free status to produce passive immunotherapeutics derived from caprine (goat) polyclonal antibodies to treat a range of life-threatening infectious and/or ...
- Lentigen Corporation Receives Four Research Grants From the National Institutes of Health 15 May 2008 14:25 GMT
... Lentigen will apply its proprietary lentiviral vector (LV) technology to the development of novel immunotherapeutic treatments for diseases of high unmet medical need: -- Melanoma, with Michael Nishimura, Ph.D, ...
- AVANT to Report First Quarter 2008 Financial Results on May 19, 2008 15 May 2008 06:53 GMT
... via the company's website www.avantimmune.com approximately two hours after the live call. About AVANT Immunotherapeutics, Inc. AVANT Immunotherapeutics, Inc. is a NASDAQ-listed company discovering and developing innovative vaccines and ...
- Researchers find first conclusive evidence of Alzheimer's-like brain tangles in nonhuman primates 15 May 2008 06:17 GMT
... primate species with the hope of identifying the correct target for new drugs and immunotherapy. Rosen noted Yerkes has provided her with unparalleled access to resources for graduate-level research and ...
- Therapeutic vaccine prolongs survival and improves quality of life 15 May 2008 06:16 GMT
... of the American Urological Association in Orlando. In recent years, the concept of vaccine immunotherapy for advanced prostate cancer has become increasingly high profile as research has expanded. Major advances ...
- Therapeutic Vaccine Prolongs Survival and Improves Quality of Life in Patients with Metastatic Prost 15 May 2008 05:58 GMT
... of the American Urological Association in Orlando. In recent years, the concept of vaccine immunotherapy for advanced prostate cancer has become increasingly high profile as research has expanded. Major advances ...
- Researchers find first conclusive evidence of Alzheimer's-like brain tangles in nonhuman primates 14 May 2008 23:07 GMT
... primate species with the hope of identifying the correct target for new drugs and immunotherapy. Rosen noted Yerkes has provided her with unparalleled access to resources for graduate-level research and ...
1 - 25 of 165 next >
News by PR Newswire
|
| Tip of the day
Related Newsletters
Come and Visit
|
|
| | |
